Cellectar Biosciences Inc, has announced its first quarter results for the FY-2015. The results shows Net loss per shares of -$0.30 widens by 70% Y/Y, and Operating Cash flow went up to $2.4 million rise by 7.7%. View the full earnings release here.
Kindred Biosciences, Inc., has announced its results for the first quarter of FY-2015. The results shows EPS went improves from, -$0.38 to -$0.34 YoY, whereas cash and Equivalents also went down to $94.589 Million from $101.027 Million Quarterly. View the full earnings here.
Coronado Biosciences, Inc., has a formed a new sub company DiaVax Biosciences, to develop novel immuno- therapies for the prevention and treatment of cytomegalovirus (CMV). View the full release here.
Calithera Biosciences, Inc. has announced its Annual Financial Results showing Net Loss of $6.83 Million whereas Cash Assets rise at 42%. Annual Loss from operations was $21.7 million. View the full earnings release here.